Phase I, Open Label, Randomized Study to Examine the Pharmacokinetics, Safety and Tolerability of Different Oral Doses of TMC435 After Single and Repeated Dosing in Healthy Chinese Subjects.
Phase of Trial: Phase I
Latest Information Update: 20 Jun 2014
At a glance
- Drugs Simeprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 19 Mar 2012 Actual initiation date changed from 1 Nov 2010 to 1 Oct 2010 as reported by ClinicalTrials.gov.
- 27 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Nov 2010 Actual initiation date (November 2010) added as reported by ClinicalTrials.gov.